|
Vice
President-Research and Chief Scientific Officer - Dr. William
Jia, Ph.D.
Dr. William
Jia is Associate Professor at University of British Columbia
and Senior Scientist at BC Cancer Research Centre. He
is also a prestigious Canadian Institute of Health Research
(CIHR) Scholar. He has 31 peer reviewed publications on the
brain and/or cancer. Dr. Jia leads the Company's research programs.
Director
of Finance and Administration - Mr. James Cao, MBA,
MSc, CFA
Mr. Cao has over 10
years of experience in treasury, investment management, and
accounting. Prior to joining Panagin, James worked for UBC Sauder
School of Business as a consultant and was the Executive Manager
of Investment Division of a large holding company in Shanghai
China, where he managed the whole investment portfolio.
Senior
Scientist - Dr. William Campbell, Ph.D.
Dr. Campbell
has over 30 year of experience in the field of protein chemistry.
In 1989, while in Japan as an associate professor at Nagoya
City University he discovered a novel enzyme, carboxypeptidase
R, an important regulator of inflammation and fibrinolysis.
Over the past several years he has made use of novel computer
algorithms that create peptide antibody mimetics to targets
in proteins and has used peptide array technology to identify
potential drug candidates for both therapeutic and diagnostic
applications. After leaving Japan, Dr. Campbell spent two years
as visiting scientist at the Kinsmen Laboratory of Neurological
Research at the University of British Columbia before joining
Panagin.
Dr.
James Goldie, MD, FRCPC
Dr. Goldie is
Clinical Emeritus Professor at University of British Columbia, former
Head of Medical Oncology of BC Cancer Agency. Dr. Goldie is a global
leader in oncology, especially in the field of drug resistant cancer
treatment and research. His theory (Goldie-Coldman Hypothesis) on
cancer drug resistance is quoted in almost all of today's major
oncology textbooks. Dr. Goldie has more than 200 peer-reviewed
publications and 29 textbook or chapters to his credit in the area
of oncology. Dr. Goldie advises PanaGin on clinical strategies
and clinical trial protocol development.
Dr.
Francis Law, Ph.D.
Dr. Francis Law is currently a Professor in the
Department of Biological Sciences at Simon Fraser University. Dr.
Francis Law's research interests include preclinical and clinical
studies on safety and efficacy of biopharmaceuticals, nutraceuticals
and natural health products especially Chinese herbal medicine;
pharmacokinetic studies using laboratory animals and humans; application
of classical and physiologically based pharmacokinetic(PBPK) models
in herb research and development; in vitro prediction of drug/herb
interactions using human liver microsomes and Caco-2 cells; analysis
of active herbal components using GC/MS and HPLC/MS/MS; registration
submission to Health Canada and US Food and Drug Administration
for drugs and herbal products; environmental risk assessment of
new drug and herbal products; and GLP, GCP and GMP compliance.
Dr.
David Osoba, MD, FRCPC
Dr. David
Osoba was a Professor of Medicine (Retired) at the University
of British Columbia, and former Vice-President of the British
Columbia Cancer Agency. With clinical background in medical
oncology, Dr. David Osoba has research experience in immunology,
clinical trials and quality-of-life measurement. For the past
17 years, he has been a member of the Quality of Life Committee
of the Clinical Trials Group of the National Cancer Institute
of Canada (Chair from 1986-1996) and a member of the Board of
Directors and immediate past president of the International
Society for Quality of Life research (ISOQOL). Also, he was
an Associate Editor of Quality of Life Research from its inception
in 1992 until 2001. Dr. Osoba has more than 250 scientific publications
to his credit. Dr. Osoba advises Panagin on clinical trial protocol
development and data review.
Mr.
Winter Huang, Chairman
Mr. Huang
is a versatile entrepreneur with many years of experience in
a variety of business fields and has a keen interest in the
development of cutting-edge biotechnology. Mr. Huang is the
principal inventor of Panagin's core patents.
Mr.
Victor Ding, MBA
Mr. Ding,
a seasoned financial manager, is a co-founder of Panagin.
Dr.
Peter Sun
Dr.
William Jia
|
